Personalised cancer treatment
We know that every person is unique, so we believe their cancer care should be too. Our experts in personalised cancer care design health care tailored to the unique needs of each person.
The outcomes of our research into predictive profiling, analysis, and tailored interventions contribute to:
- informed decision-making by health services
- delivery of cancer treatment optimised for each individual.
Research
Our research is contributing to the future of medicine - where each person's care is tailored to them.
Education
We contribute to ongoing professional education programs for cancer care professionals.
Advocacy
Our people actively advocate for individualised cancer care with government and health service organisations.
Leadership
Our people hold leadership positions within patient and practitioner peak bodies.
Chemotherapy-Induced Peripheral Neuropathy Clinical Trial
The Personalised Cancer Care team is running a clinical trial to examine which self-managed treatments (heat or massage) reduce the symptoms of chemotherapy-induced peripheral neuropathy. The aim of the trial is to assist cancer patients to maintain a high-level quality of life after treatment. Please note that recruitment for this trial is now complete.
Find out more about the trial via Chemotherapy-Induced Peripheral Neuropathy.
Chemotherapy-Induced Peripheral Neuropathy (CIPN) clinical trial
The Chemotherapy-Induced Peripheral Neuropathy (CIPN) clinical trial aims to find which self-managed treatments (heat or massage) reduce the symptoms of peripheral neuropathy.
Visit CIPN